| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO and Director | President and CEO | Chief Executive Officer
1 company
Vitt Daniel serves as a CEO and Director at IMUX. Across recent SEC filings that breaks down to 5 buys and 2 sells. Those positions are worth an estimated $22K at current prices.
Historically, Vitt Daniel's trades have earned a middling insider score of 57/100 across 5 rated trades. Over a 12-month horizon, 20.0% of those trades were profitable, with an average 12-month return of -6.2%.
The biggest single holding is IMUX (~$22K) as CEO and Director. Net of sales, the recent Form 4 record there shows accumulation of 36,700 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 4, 2025 | IMUX Immunic, Inc. | CEO and Director | Buy | 15,000 | $0.77 | $11,550.00 | +107.1% | +3.1% | +1761.9% | |
| Feb 26, 2024 | IMUX Immunic, Inc. | President and CEO | Buy | 14,000 | $1.31 | $18,333.00 | +3.7% | -2.3% | -10.2% | |
| Nov 22, 2022 | IMUX Immunic, Inc. | President and CEO | Buy | 8,000 | $1.35 | $10,799.20 | +2.2% | +46.6% | -19.8% | |
| Jun 3, 2022 | IMUX Immunic, Inc. | President and CEO | Buy | 5,000 | $3.10 | $15,499.50 | +1.4% | +31.3% | -53.4% | |
| Aug 10, 2021 | IMUX Immunic, Inc. | President and CEO | Buy | 1,000 | $9.60 | $9,600.00 | +0.3% | +1.3% | -47.4% | |
| Jul 21, 2020 | IMUX Immunic, Inc. | Chief Executive Officer | Sell | 6,300 | $14.68 | $92,510.27 | -1.7% | - | - |